• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持药物开发的电子患者报告结局数据集结构和标准化的最佳实践推荐

Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development.

机构信息

Clinical Outcomes Solutions, Tucson, AZ, USA.

Electronic Clinical Outcome Assessment (eCOA) Consortium, Critical Path Institute, Tucson, AZ, USA.

出版信息

Value Health. 2023 Aug;26(8):1242-1248. doi: 10.1016/j.jval.2023.02.011. Epub 2023 Feb 26.

DOI:10.1016/j.jval.2023.02.011
PMID:36849080
Abstract

The electronic patient-reported outcome (ePRO) Dataset Structure and Standardization Project is a multistakeholder initiative formed by Critical Path Institute's PRO Consortium and Electronic Clinical Outcome Assessment (eCOA) Consortium to address issues related to ePRO dataset structure and standardization and to provide best practice recommendations for clinical trial sponsors and eCOA providers. Given the many benefits of utilizing electronic modes to capture PRO data, clinical trials are increasingly using these methods, yet there are challenges to using data generated by eCOA systems. Clinical Data Interchange Standards Consortium (CDISC) standards are used in clinical trials to ensure consistency in data collection, tabulation, and analysis and to facilitate regulatory submission. Currently, ePRO data are not required to follow a standard model, and the data models used often vary by eCOA provider and sponsor. This lack of consistency creates risks for programming and analysis and difficulties for analytics functions generating the required analysis and submission datasets. There is a disconnect between data standards used for study data submission and those used for data collection via case report forms and ePRO forms, which would be mitigated through the application of CDISC standards for ePRO data capture and transfer. The project was formed to collate and examine the issues arising from the lack of adoption of standardized approaches and this paper details recommendations to address those issues. Recommendations to address issues with ePRO dataset structure and standardization include adopting CDISC standards in the ePRO data platform, timely involvement of key stakeholders, ensuring ePRO controls are implemented, addressing issues of missing data early in development, ensuring quality control and validation of ePRO datasets, and use of read-only datasets.

摘要

电子患者报告结局 (ePRO) 数据集结构和标准化项目是由关键路径研究所的 PRO 联盟和电子临床结局评估 (eCOA) 联盟组成的多方利益相关者倡议,旨在解决与 ePRO 数据集结构和标准化相关的问题,并为临床试验赞助商和 eCOA 提供商提供最佳实践建议。鉴于利用电子模式采集 PRO 数据有许多好处,临床试验越来越多地使用这些方法,但在使用 eCOA 系统生成的数据时存在挑战。临床数据交换标准协会 (CDISC) 标准用于临床试验,以确保数据收集、制表和分析的一致性,并促进监管提交。目前,ePRO 数据不需要遵循标准模型,并且使用的数据模型通常因 eCOA 提供商和赞助商而异。这种不一致性为编程和分析带来了风险,并为生成所需分析和提交数据集的分析功能带来了困难。用于研究数据提交的数据标准与用于通过病例报告表和 ePRO 表单进行数据收集的数据标准之间存在脱节,如果通过应用 CDISC 标准进行 ePRO 数据采集和传输,这种脱节情况将会得到缓解。该项目的成立是为了整理和检查由于缺乏采用标准化方法而产生的问题,本文详细介绍了解决这些问题的建议。解决 ePRO 数据集结构和标准化问题的建议包括在 ePRO 数据平台中采用 CDISC 标准、及时让关键利益相关者参与、确保实施 ePRO 控制、在开发早期解决数据缺失问题、确保 ePRO 数据集的质量控制和验证、以及使用只读数据集。

相似文献

1
Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development.支持药物开发的电子患者报告结局数据集结构和标准化的最佳实践推荐
Value Health. 2023 Aug;26(8):1242-1248. doi: 10.1016/j.jval.2023.02.011. Epub 2023 Feb 26.
2
Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically.最佳实践推荐:用于电子收集临床结果评估数据的系统的用户接受测试。
Ther Innov Regul Sci. 2022 May;56(3):442-453. doi: 10.1007/s43441-021-00363-z. Epub 2022 Mar 1.
3
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.关于支持电子和纸质患者报告结局(PRO)测量等效性所需证据的建议:国际药物经济学与结果研究协会(ISPOR)电子PRO良好研究实践工作组报告
Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.
4
Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: report of the ISPOR ePRO systems validation good research practices task force.电子系统采集患者报告结局(PRO)数据的验证——临床试验团队的建议:ISPOR ePRO 系统验证良好研究实践工作组报告。
Value Health. 2013 Jun;16(4):480-9. doi: 10.1016/j.jval.2013.04.002.
5
Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium.关于在临床试验中运用技术以电子方式收集患者报告结局数据的培训:电子患者报告结局联盟的最佳实践建议
Ther Innov Regul Sci. 2019 Jul;53(4):431-440. doi: 10.1177/2168479018796206. Epub 2018 Sep 16.
6
Flexible approaches to eCOA administration in clinical trials: The site perspective.临床试验中电子临床结局评估(eCOA)管理的灵活方法:来自研究站点的观点
Contemp Clin Trials Commun. 2023 Dec 7;37:101241. doi: 10.1016/j.conctc.2023.101241. eCollection 2024 Feb.
7
Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.临床数据交换标准协会(CDISC)标准在真实世界数据中的应用:来自定性德尔菲调查的专家观点
JMIR Med Inform. 2022 Jan 27;10(1):e30363. doi: 10.2196/30363.
8
Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials.在临床试验中采用电子方式收集患者报告结局数据时避免纸质备份的最佳实践
Ther Innov Regul Sci. 2019 Jul;53(4):441-445. doi: 10.1177/2168479018785160. Epub 2018 Sep 24.
9
Optimizing Electronic Capture of Clinical Outcome Assessment Data in Clinical Trials: The Case of Patient-Reported Endpoints.优化临床试验中临床结局评估数据的电子采集:以患者报告的终点为例
Ther Innov Regul Sci. 2015 Nov;49(6):797-804. doi: 10.1177/2168479015609102.
10
Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium.可穿戴设备的选择和证据考虑因素及其在监管决策中的使用测量:ePRO 联盟的建议。
Value Health. 2018 Jun;21(6):631-639. doi: 10.1016/j.jval.2017.09.012. Epub 2017 Nov 7.

引用本文的文献

1
Assessing usability of electronic patient-reported outcome measures in older people with and without a rare dermatologic disorder.评估电子患者报告结局指标在患有和未患罕见皮肤病的老年人中的可用性。
J Patient Rep Outcomes. 2024 Dec 18;8(1):145. doi: 10.1186/s41687-024-00821-w.
2
Feasibility and acceptability of wearing a neuromodulation device at night in individuals in recovery from opioid use disorder.阿片类物质使用障碍康复者夜间佩戴神经调节设备的可行性和可接受性。
Front Psychiatry. 2024 Nov 29;15:1481795. doi: 10.3389/fpsyt.2024.1481795. eCollection 2024.
3
Data collection methods for patient-reported outcome measures in cancer randomised controlled trials: a protocol for a rapid scoping review.
癌症随机对照试验中患者报告结局测量数据收集方法的快速范围综述研究方案。
BMJ Open. 2024 Sep 10;14(9):e084935. doi: 10.1136/bmjopen-2024-084935.
4
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance.如何选择和理解患者报告结局指南:现有指南的范围综述。
BMC Health Serv Res. 2024 Mar 13;24(1):334. doi: 10.1186/s12913-024-10707-8.